HIGHS Lively handling, upscale and spacious interior, cheeky styling outside and in. LOWS Uncommunicative steering, laggy infotainment system, a little slower than its predecessor. VERDICT Though it's ...

SCS combined with HIPEC may improve overall survival in PSROC patients compared to SCS alone, with a statistically significant benefit observed. The risk of severe complications, including anemia and ...

FOX CHASE (WPVI) -- HIPEC is an often overlooked form of chemotherapy, with a long track record. It's improving survival rates in some abdominal cancers, however, some patients and doctors may not ...

Patients with advanced ovarian cancer undergoing interval cytoreductive surgery who received paclitaxel-based hyperthermic intraperitoneal chemotherapy (HIPEC) during surgery appeared to have ...

Please provide your email address to receive an email when new articles are posted on . In this video, Robert DeBernardo, MD, discusses his research on hyperthermic intraperitoneal chemotherapy among ...

Adding HIPEC to CRS did not show any added benefit but has shown increased toxicities in patients with colorectal peritoneal metastasis. In an interview with CancerNetwork®, Muhammad Talha Waheed, MD, ...

Amber and her family in the Volkswagen convertible she bought after learning she was cancer-free Amber used to live her life with anxiety and fear—always trying to stay within her comfort zone. She ...

Muhammad Talha Waheed, MD, stated that a retrospective study found an OS benefit in CRC peritoneal metastasis with cytoreduction surgery without HIPEC vs with HIPEC. CancerNetwork® interviewed ...

HIPEC stands for hyperthermic intraperitoneal chemotherapy. It’s a cancer treatment that pumps warm chemotherapy drugs into your abdomen. You get one very large dose of chemotherapy, but it's not as ...

HIPEC addition to SCS did not improve progression-free survival in platinum-sensitive recurrent ovarian cancer patients. Both SCS alone and SCS with HIPEC groups exhibited similar safety profiles, ...

Patients with recurrent platinum-sensitive ovarian cancer did just as well with cytoreductive surgery alone as they did with surgery plus intraperitoneal chemotherapy, according to a randomized trial.